phosphatidylcholines has been researched along with pirfenidone in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (pirfenidone) | Trials (pirfenidone) | Recent Studies (post-2010) (pirfenidone) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,094 | 102 | 883 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | pirfenidone (IC50) |
|---|---|---|---|
| Transforming growth factor beta-1 proprotein | Mus musculus (house mouse) | 1.43 | |
| Mothers against decapentaplegic homolog 3 | Mus musculus (house mouse) | 1.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, A; Miyazaki, Y; Mizushima, T; Sato, K; Tanaka, KI | 1 |
1 other study(ies) available for phosphatidylcholines and pirfenidone
| Article | Year |
|---|---|
Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Free Radical Scavengers; Lung; Mice; Phosphatidylcholines; Pulmonary Fibrosis; Pyridones; Superoxide Dismutase; Treatment Outcome; Vital Capacity | 2012 |